Company Participants James Hart - Investor Relations Peter Anevski - Chief Executive Officer Michael Sturmer - President Mark Livingston - Chief Financial Officer Anne Samuel - JPMorgan Michael Cherny - Leerink Partners Glen Santangelo - Jefferies Allen Lutz - Bank of America Scott Schoenhaus - KeyBanc Sarah James - Cantor Fitzgerald Jailendra Singh - Truist Securities Stephanie Davis - Barclays Jenny Shen - BTIG Good day, ladies and gentlemen, and welcome to the Progyny, Inc. Fourth Quarter 2023 Earnings C ...

Reports Record Full Year Revenue of $1,088.6 Million, Reflecting 38% Growth Achieves 49% Growth in Adjusted EBITDA to Record $187.1 Million Issues Financial Guidance for 2024, Crossing the $1.3 Billion Milestone at Midpoint NEW YORK, February 27, 2024 /GlobeNewswire/ - Progyny, Inc. (Nasdaq: PGNY) ("Progyny" or the "Company"), a transformative fertility, family building and women's health benefits solution, today announced its financial results for the three- and twelve-month periods ended December 31, 2023 ...

Table of contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ____________________________________________ FORM 10-Q ____________________________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________________ to ___________________ Com ...

James Hart - IR Pete Anevski - CEO Michael Sturmer - President Mark Livingston - CFO Good day, everyone, and welcome to the Progyny, Inc. Third Quarter 2023 Earnings Call. [Operator Instructions] It is now my pleasure to turn the floor over to your host, James Hart. Sir, the floor is yours. Company Participants Anne Samuel - JPMorgan Scott Schoenhaus - KeyBanc Jailendra Singh - Truist Securities Sarah James - Cantor Richard Close - Canaccord Allen Lutz - Bank of America David Larsen - BTIG James Hart Before ...

Table of contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ____________________________________________ FORM 10-Q ____________________________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________________ to ___________________ Commissi ...

These include leading brands in manufacturing, healthcare, financial services, automotive and professional services to name just a few. And even though this is just our first full year of targeting Taft-Hartley groups, we're also seeing strong demand as well as early commitments from labor union populations. Thus far, these early commitments are choosing comparable levels of coverage to what we've seen in the past seasons, and we're also continuing to see a high take rate on Progyny Rx, both of which indica ...

Table of contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ____________________________________________ FORM 10-Q ____________________________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________________ to ___________________ Commiss ...

The next question is from Sarah James with Cantor Fitzgerald. Please proceed. Sarah James Hi, thank you. I was hoping you could give us a little bit more color about the Evernorth arrangement and how the sales process integrates. So should we think about this as a push or a pull? So can their sales team be pushing or selling Progyny benefits? Or is it more a pull where if one of their clients is looking for fertility, they let them know that Progyny is integrated? Pete Anevski Yes. Thanks for your question, ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________________ to ___________________ Commission File Number: 001-39100 Progyny, Inc. (Exact name of registrant as specified in its charter) ...

Progyny, Inc. (NASDAQ:PGNY) Q4 2022 Earnings Conference Call February 27, 2023 4:45 PM ET Company Participants James Hart - Vice President of Investor Relations Peter Anevski - Chief Executive Officer Mark Livingston - Chief Financial Officer Michael Sturmer - President Conference Call Participants Michael Cherny - Bank of America Jailendra Singh - Truist Securities Scott Schoenhaus - KeyBanc Stephanie Davis - SVB Securities Operator Good day, ladies and gentlemen and welcome to the Progyny Inc. Fourth Quar ...